Noven is a fully-integrated specialty pharmaceutical company with industry-leading transdermal expertise

Products

Therapeutic Areas

Noven’s commercialized products and product development activities are principally focused in the areas of women’s health and mental health, including ADHD and schizophrenia.

For additional information on our therapeutic areas of focus and related products, click on the tabs above.


Product

Indication
Regulatory Status Marketing
Rights
Daytrana®
(methylphenidate transdermal system)

Full Prescribing Information
& Boxed Warning
ADHD in children and adolescents
6-17 years old
Marketed in U.S. Noven
Minivelle®
(estradiol transdermal system)

Full Prescribing Information
& Boxed Warning
Moderate to severe vasomotor symptoms due to menopause and prevention of post-menopausal osteoporosis Marketed in U.S. Noven
CombiPatch®
(estradiol / NETA transdermal system)

Full Prescribing Information
& Boxed Warning
Moderate to severe vasomotor symptoms; moderate to severe vulvar and vaginal atrophy; treatment of hypoestrogenism Marketed in U.S. Noven
Estradiol Transdermal System

Full Prescribing Information
& Boxed Warning
Moderate to severe vasomotor symptoms due to menopause and prevention of post-menopausal osteoporosis Marketed in U.S. Noven
Secuado®
(asenapine) transdermal system

Full Prescribing Information
& Boxed Warning
Schizophrenia in adults Approved in U.S. Noven

 

More Information

Minivelle® and CombiPatch®
Patient, Physician
and Pharmacist Inquiries:

Tel: 800-455-8070

Daytrana® Patient, Physician
and Pharmacist Inquiries:

Tel: 877-567-7857

Secuado® Patient, Physician and
Pharmacist Inquiries:

Tel: 800-455-8070